Pharmaceutical inhibition of AXL suppresses tumor growth and invasion of esophageal squamous cell carcinoma.
In conclusion, the results of the present study suggested that R428 treatment may suppress ESCC tumor cell proliferation and invasion, representing a potential therapeutic target for ESCC.
PMID: 32952632 [PubMed]
Source: Experimental and Therapeutic Medicine - Category: General Medicine Tags: Exp Ther Med Source Type: research
More News: African Health | Cancer | Cancer & Oncology | Carcinoma | Esophagus Cancer | General Medicine | Iran Health | Middle East Health | Skin Cancer | South Africa Health | Squamous Cell Carcinoma | Study